期刊文献+

非小细胞肺癌EGFR突变状况与脑转移研究进展 被引量:12

Research progress of brain metastasis in non-small cell lung cancer with different EGFR gene status
原文传递
导出
摘要 目的:总结非小细胞肺癌EGFR突变状态与脑转移的研究进展,探讨EGFR突变非小细胞肺癌脑转移治疗策略。方法:应用PubMed和CNKI期刊全文检索系统,以"非小细胞肺癌脑转移、靶向治疗和全脑放疗"为关键词,共检索到2004-2013年相关文献270篇,其中英文文献160篇,中文文献110篇。纳入标准:1)非小细胞肺癌脑转移与EGFR突变状态关系;2)表皮生长因子受体酪氨酸激酶抑制剂(epidermal growth factor receptor-tyrosine kinase inhibitors,EGFR-TKIs)在非小细胞肺癌脑转移中的作用;3)非小细胞肺癌脑转移全脑放疗。根据纳入标准分析文献30篇。结果:EGFR突变NSCLC脑转移患者TKIs治疗敏感,同时中枢转移灶放疗亦敏感,而EGFR野生型及TKIs获得性耐药患者中枢转移灶放疗抵抗;EGFR突变状态与NSCLC脑转移患者TKIs治疗疗效、放疗疗效、生存及预后明显相关。结论:EGFR基因突变状态在指导NSCLC脑转移患者治疗、预测预后方面具有重要的作用。 OBJECTIVE:To summarize the progress of brain metastasis in non-small cell lung cancer with different EGFR gene status,discuss non-small cell lung cancer with EGFR mutations brain metastasis treatment strategies.METHODS:The full text database of PubMed and CNKI were searched,and the words"non-small cell lung cancer with brain metastasis","targeted therapy"and"whole-brain radiotherapy"were used as key words.Totally 270related articles were retrieved between the year of 2004and 2013with 160papers of literature in English and 110in Chinese.The selection standards for the date related:1)Non-small cell lung cancer with brain metastasis relationship with EGFR mutation status; 2)Epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer with brain metastasis;3)Nonsmall cell lung cancer with brain metastasis whole brain radiotherapy.According to the standards mentioned above,30papers were finally selected and analyzed.RESULTS:NSCLC patients with brain metastases and EGFR mutations are sensitive to TKIs,but the central nervous metastases also are sensitive to radiotherapy,whereas the brain metastases patients with wild-type and TKIs acquired resistance are radiation resistance.There are significantly correlation between EGFR mutations status and NSCLC patients with brain metastases to TKIs therapy,radiotherapy,survival and prognosis.CONCLUSION:EGFR mutation status are impotant in guiding treatment,predicting the prognosis of NSCLC patients with brain metastases.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2014年第10期795-799,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81172225)
关键词 非小细胞肺癌 脑转移 表皮生长因子受体 综述文献 non-small cell lung cancer brain metastasis epidermal growth factor receptor literature review
  • 相关文献

参考文献30

  • 1Petrosyan F,Daw H,Haddad A,et al. Targeted therapy for lung cancer [J]. Anticancer Drugs,2012,23(10):1016-1021.
  • 2Ding K,Pater J,Whitehead M, et al. Validation of treatment in- duced specific adverse effect as a predictor of treatment benefit: a case study of NCIC CTG BR21 [J]. Contemporary clinical trials, 2008,29(4) : 527-536.
  • 3程刚.非小细胞肺癌的分子靶向药物治疗[J].中华肿瘤防治杂志,2007,14(5):387-390. 被引量:6
  • 4Burel-Vandenbos F, Ambrosetti D, Coutts M, et al. EGFR muta- tion status in brain metastases of non-small cell lung carcinoma [J]. J Neurooncol,2013,111(1) :1-10.
  • 5Eichler AF, Kahle KT,Wang DL, etal. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer [J]. Neuro Oncol,2010,12(11):1193-1199.
  • 6Sekine A, Kato T, Hagiwara E, et al. Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing in- fluence of exon 19 deletion on radiographic features [J]. Lung cancer (Amsterdam, Netherlands), 2012,77 ( 1 ) : 64-69.
  • 7Daniele L,Cassoni P,Bacillo E,et al. Epidermal growth factor re- ceptor gene in primary tumor and metastatic sites from non small cell lung cancer [J]. J Thorae Oncol, 2009,4(6): 684-688.
  • 8Matsumoto S, Takahashi K, Iwakawa R, et al. Frequent EGFR mutations in brain metastases of lung adenocarcinoma [J]. Int J Cancer,2006,119(6) : 1491 -1494.
  • 9Fidler IJ. The role of the organ microenvironment in brain metas- tasis[J].Semin Cancer Biol,2011,21(2) :107- 112.
  • 10李晓霞,李文良,马勇杰.肺癌脑转移分子机制的研究进展[J].中华肿瘤防治杂志,2013,20(5):387-391. 被引量:15

二级参考文献79

  • 1林树新,於峻.花生四烯酸代谢物对呼吸道感受器的作用[J].生理学报,2007,59(2):141-149. 被引量:13
  • 2谷铣之,殷蔚伯,刘泰福.肿瘤放射治疗学[M].4版.北京:中国协和医科大学出版社,2008:47.
  • 3Arrieta O,Saavedra-Perez D,Kuri R,et al. Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer:a prospective analysis.BMC Cancer,2009,9:119.
  • 4Chen AM,Jahan TM,Jablons DM,et al. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer:clinical implications for the subsequent management of the brain.Cancer,2007,109:1668-1675.
  • 5Siker ML,Mehta ME Resection versus radiosurgery for patients with brain metastases.Future Oncol,2007,3:95-102.
  • 6Ma S,Xu Y,Deng Q,et al.Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.Lung Cancer,2009,65:198-203.
  • 7Kim JE,Lee DH,Cboi Y,et al.Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis.Lung Cancer,2009,65:351-354.
  • 8Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States,National Cancer Institute of Canada.J Nail Cancer Inst,2000,92:205-216.
  • 9Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0:development of a comprehensive grading system for the adverse effects of cancer treatment.Semin Radiat Oncol,2003,13:176-181.
  • 10Thatcher N,Chang A,Parikh P,et al. Gefitinib plus best supportive care in previously treated patients with refractory and advanced non-small-cell lung cancer:results from a randomised,placebo-controlled,multicentre study (Iressa Survival Evaluation in Lung Cancer).Lancet,2005,366:1527-1537.

共引文献75

同被引文献127

  • 1王成祥,杨志广,邵国光.分子靶向药物治疗非小细胞肺癌相关恶性胸腔积液和恶性心包积液[J].中国老年学杂志,2014,34(9):2547-2549. 被引量:3
  • 2王燕,王颖,王彬,王子平,张湘茹,储大同,孙燕.吉非替尼治疗非小细胞肺癌脑转移的初步结果[J].中国肺癌杂志,2006,9(5):447-451. 被引量:33
  • 3刘炬,张雪梅,张湘茹,袁芃,徐兵河,林东昕.ERCC6 C6530G单核苷酸多态与局限期小细胞肺癌患者生存相关[J].中国癌症杂志,2006,16(11):943-947. 被引量:7
  • 4Komatsu T, Kunieda E,Oizumi Y,et al. Clinical characteristics ofbrain metastases from lung cancer according to histological type:Pretreatment evaluation and survival following whole-brain ra-diotherapy [J]. Mol Clin Oncol,2013,1(4) :692-698.
  • 5Tsao MN, Lloyd N, Wong RKS, et al. Whole brain radiotherapyfor the treatment of newly diagnosed multiple brain metastases[J]. Cochrane Database Syst Rev,2012,4 :CD003869.
  • 6Patil CG, Pricola K,Sarmiento JM, et al. Whole brain radiationtherapy (WBRT) alone versus WBRT and radiosurgery for thetreatment of brain metastases [J]. Cochrane Database Syst Rev(Online),2012,9:CD006121.
  • 7Zhuang HQ, Yuan ZY, Wang J, et al. Phase H study of wholebrain radiotherapy with or without erlotinib in patients with mul-tiple brain metastases from lung adenocarcinoma [J]. Drug DesDevel Ther,2013,7:1179-1186.
  • 8Welsh JW, Komaki R, Amini A, et al. Phase H trial of erlotinibplus concurrent whole-brain radiation therapy for patients withbrain metastases from non-small-cell lung cancer [J], J Clin On-col,2013,31(7) :895-902.
  • 9Pesce GA,Klingbiel D’Ribi K,et al. Outcome, quality of life andcognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy com-bined with gefitinib or temozolomide. A randomised phase II tri-al of the Swiss Group for Clinical Cancer Research (SAKK 70/03)[J]. Eur J Cancer,2012,48(3) :377-384.
  • 10Sperduto PW, Wang M,Robins HI,et al. A phase 3 trial of wholebrain radiation therapy and stereotactic radiosurgery alone versusWBRT and SRS with temozolomide or erlotinib for non-small celllung cancer and 1 to 3 brain metastases : Radiation Therapy On-cology Group 0320 [J]. Int J Radiat Oncol Biol Phys, 2013 , 85.5):1312-1318.

引证文献12

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部